MK-2048 10mg 10mg | Purity Not Available
Adooq Bioscience
MK-2048 is a second generation integrase inhibitor, intended to be used against HIV infection.
More Information Supplier PageSearch Results
CH5424802 50mg 50mg | Purity Not Available
Adooq Bioscience
CH5424802 is a potent, selective, and orally available ALK inhibitor with a unique chemical scaffold, showing preferential antitumor activity against cancers with gene alterations of ALK.
More Information Supplier PageCH5424802 5mg 5mg | Purity Not Available
Adooq Bioscience
CH5424802 is a potent, selective, and orally available ALK inhibitor with a unique chemical scaffold, showing preferential antitumor activity against cancers with gene alterations of ALK.
More Information Supplier PageCH5424802 100mg 100mg | Purity Not Available
Adooq Bioscience
CH5424802 is a potent, selective, and orally available ALK inhibitor with a unique chemical scaffold, showing preferential antitumor activity against cancers with gene alterations of ALK.
More Information Supplier PageCH5424802 10mg 10mg | Purity Not Available
Adooq Bioscience
CH5424802 is a potent, selective, and orally available ALK inhibitor with a unique chemical scaffold, showing preferential antitumor activity against cancers with gene alterations of ALK.
More Information Supplier PageLaquinimod (ABR-215062) 5mg 5mg | Purity Not Available
Adooq Bioscience
Laquinimod (ABR-215062) 25mg 25mg | Purity Not Available
Adooq Bioscience
Laquinimod (ABR-215062) 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
Laquinimod (ABR-215062) 10mg 10mg | Purity Not Available
Adooq Bioscience
MK-0812 50mg 50mg | Purity Not Available
Adooq Bioscience
MK-0812 is a potent and selective CCR2 antagonist with low nM affinity for CCR2 on human monocytes and low nM in the chemotaxis assay. It has good PK profiles in preclinical species and demonstrated efficacy in animal models.
More Information Supplier Page